GeoVax Labs (GOVX) SEC Filings: History & Chart

GeoVax Labs, Inc.(GOVX)

Biotechnology · Smyrna, GA

$0.29-0.03 (-8.91%)

Delayed quote: Oct 6, 2026, 3:20 PM EDT

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.

Smyrna, GA

19 employees

www.geovax.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David Alan Dodd

View full financials

Form	Filing Date	Accepted	Document
EFFECT	Sep 23, 2026	Sep 24, 2026	View filing
S-1	Sep 17, 2026	Sep 17, 2026	View filing
DEF 14A	Sep 10, 2026	Sep 10, 2026	View filing
8-K	Sep 10, 2026	Sep 10, 2026	View filing
PRE 14A	Aug 31, 2026	Aug 31, 2026	View filing
8-K	Aug 28, 2026	Aug 28, 2026	View filing
8-K	Aug 28, 2026	Aug 28, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
SC 13G/A	Aug 13, 2026	Aug 13, 2026	View filing
SC 13G/A	Aug 13, 2026	Aug 13, 2026	View filing
SC 13G/A	Aug 10, 2026	Aug 10, 2026	View filing
10-Q	Jul 27, 2026	Jul 27, 2026	View filing
8-K	Jul 27, 2026	Jul 27, 2026	View filing
8-K	Jul 10, 2026	Jul 10, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
8-K	Jun 17, 2026	Jun 17, 2026	View filing
SC 13G	Jun 9, 2026	Jun 9, 2026	View filing
EFFECT	Jun 3, 2026	Jun 4, 2026	View filing
S-1	May 26, 2026	May 26, 2026	View filing
8-K	May 19, 2026	May 19, 2026	View filing

SEC Filings

Recent Filings